Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
Quick Stats
Jan 30, 202653.4
AI Score
HOLD0.03
Volume Ratio
Mar 12, 2026
Next Earnings
10
+ve Days (30d)
17
-ve Days (30d)
RDHL Stock Summary
Last updated Jan 30, 2026
RDHL is currently trading at $1.22, positioned below its 200-day moving average of $1.59, suggesting bearish momentum. The stock has a 52-week range of $0.905 to $6.26.
Technical Analysis: The 50-day moving average stands at $1.2, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 45.796, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.762, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RDHL at 53.4/100 with a HOLD recommendation.
RDHL (Redhill Biopharma Ltd.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 45.796 |
| CMF (20) | 0.762 |
| ROC (10) | -6.87 |
| ADX (14) | 11.911 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.021 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -77.273 |
| MFI (14) | 54.176 |
RDHL Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RDHL Price vs Max Options Open Interest
RDHL Max Change In Options Open Interest
RDHL Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RDHL Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RDHL Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RDHL Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Redhill Biopharma Ltd. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
RDHL Moving Averages Analysis
Redhill Biopharma Ltd. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
RDHL (Redhill Biopharma Ltd.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.31 |
| 20 | 1.29 |
| 30 | 1.24 |
| 50 | 1.2 |
| 100 | 1.39 |
| 200 | 1.59 |
RDHL Fundamental Analysis
| P/E (Forward) | 1428.5714 |
| P/E (Trailing) | 0 |
| Market Cap ($) | 6.6 million |
| Earnings/Share ($) | 0 |
| Net Proft Margin (%) | -0.9752 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | 19000 |
| Most Recent Quarter |